How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
12
PD Quote, Financials, Valuation and Earnings
Last price:
$14.99
Seasonality move
:
-4.97%
Day range:
$14.63 - $15.03
52-week range:
$14.30 - $23.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.84x
P/B ratio:
10.14x
Volume:
1M
Avg. volume:
1.4M
1-year change:
-29.89%
Market cap:
$1.3B
Revenue:
$467.5M
EPS (TTM):
-$0.59
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $213.6M | $281.4M | $370.8M | $430.7M | $467.5M | |
| Revenue Growth (YoY) | 28.38% | 31.77% | 31.77% | 16.16% | 8.54% | |
| Cost of Revenues | $30.7M | $48.4M | $70.4M | $77.8M | $79.7M | |
| Gross Profit | $182.9M | $233M | $300.4M | $352.9M | $387.8M | |
| Gross Profit Margin | 85.63% | 82.81% | 81.01% | 81.93% | 82.96% | |
| R&D Expenses | $64.6M | $95.7M | $134.9M | $139.8M | $141.5M | |
| Selling, General & Admin | $184.6M | $239.1M | $294.9M | $309.3M | $306.1M | |
| Other Inc / (Exp) | -$794K | -$573K | -$637K | $3.3M | -$215K | |
| Operating Expenses | $249.2M | $334.7M | $429.7M | $449.1M | $447.6M | |
| Operating Income | -$66.3M | -$101.7M | -$129.4M | -$96.2M | -$59.8M | |
| Net Interest Expenses | $5.7M | $4.6M | $50K | -- | -- | |
| EBT. Incl. Unusual Items | -$72.8M | -$106.9M | -$130.1M | -$77.4M | -$41.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$3.9M | $535K | -$839K | -$12K | $1.8M | |
| Net Income to Company | -$68.9M | -$107.5M | -$129.2M | -$77.4M | -$43.5M | |
| Minority Interest in Earnings | -- | -- | $802K | $2.2M | $801K | |
| Net Income to Common Excl Extra Items | -$68.9M | -$107.5M | -$128.4M | -$75.2M | -$42.7M | |
| Basic EPS (Cont. Ops) | -$0.87 | -$1.27 | -$1.45 | -$0.89 | -$0.59 | |
| Diluted EPS (Cont. Ops) | -$0.87 | -$1.27 | -$1.45 | -$0.89 | -$0.59 | |
| Weighted Average Basic Share | $79.6M | $84.5M | $88.7M | $92.3M | $92M | |
| Weighted Average Diluted Share | $79.6M | $84.5M | $88.7M | $92.3M | $92M | |
| EBITDA | -$58.3M | -$95M | -$109M | -$52.8M | -$14.5M | |
| EBIT | -$63.5M | -$103.3M | -$126.5M | -$73M | -$35.1M | |
| Revenue (Reported) | $213.6M | $281.4M | $370.8M | $430.7M | $467.5M | |
| Operating Income (Reported) | -$66.3M | -$101.7M | -$129.4M | -$96.2M | -$59.8M | |
| Operating Income (Adjusted) | -$63.5M | -$103.3M | -$126.5M | -$73M | -$35.1M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $59.3M | $78.5M | $101M | $111.1M | $121.4M | |
| Revenue Growth (YoY) | 29.09% | 32.43% | 28.6% | 10.05% | 9.3% | |
| Cost of Revenues | $9.4M | $13.9M | $18.3M | $20.4M | $20M | |
| Gross Profit | $49.9M | $64.6M | $82.6M | $90.8M | $101.5M | |
| Gross Profit Margin | 84.14% | 82.26% | 81.83% | 81.68% | 83.55% | |
| R&D Expenses | $17.9M | $27.6M | $34.6M | $35.5M | $34.6M | |
| Selling, General & Admin | $50.4M | $64.2M | $74.5M | $88.6M | $78.6M | |
| Other Inc / (Exp) | $67K | $1.4M | $689K | $256K | -$427K | |
| Operating Expenses | $68.3M | $91.8M | $109.1M | $124.2M | $113.2M | |
| Operating Income | -$18.4M | -$27.2M | -$26.5M | -$33.4M | -$11.7M | |
| Net Interest Expenses | $3.4M | $2.9M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$21.7M | -$28.7M | -$24.5M | -$28.6M | -$8.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $454K | $157K | $463K | $185K | $448K | |
| Net Income to Company | -$22.1M | -$28.9M | -$25M | -$28.8M | -$8.9M | |
| Minority Interest in Earnings | -- | -- | $440K | $665K | $120K | |
| Net Income to Common Excl Extra Items | -$22.1M | -$28.9M | -$24.6M | -$28.2M | -$8.8M | |
| Basic EPS (Cont. Ops) | -$0.27 | -$0.34 | -$0.27 | -$0.33 | -$0.12 | |
| Diluted EPS (Cont. Ops) | -$0.27 | -$0.34 | -$0.27 | -$0.33 | -$0.12 | |
| Weighted Average Basic Share | $82M | $86.1M | $90.3M | $92.6M | $90.4M | |
| Weighted Average Diluted Share | $82M | $86.1M | $90.3M | $92.6M | $90.4M | |
| EBITDA | -$15.9M | -$25.6M | -$19M | -$21.8M | -$1.7M | |
| EBIT | -$17.8M | -$27.8M | -$23.6M | -$26.9M | -$6.7M | |
| Revenue (Reported) | $59.3M | $78.5M | $101M | $111.1M | $121.4M | |
| Operating Income (Reported) | -$18.4M | -$27.2M | -$26.5M | -$33.4M | -$11.7M | |
| Operating Income (Adjusted) | -$17.8M | -$27.8M | -$23.6M | -$26.9M | -$6.7M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $213.6M | $281.4M | $370.8M | $430.7M | $467.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $30.7M | $48.4M | $70.4M | $77.8M | $79.7M | |
| Gross Profit | $182.9M | $233M | $300.4M | $352.9M | $387.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $64.6M | $95.7M | $134.9M | $139.8M | $141.5M | |
| Selling, General & Admin | $184.6M | $239.1M | $294.9M | $309.3M | $306.1M | |
| Other Inc / (Exp) | -$794K | -$573K | -$637K | $3.3M | -$215K | |
| Operating Expenses | $249.2M | $334.7M | $429.7M | $449.1M | $447.6M | |
| Operating Income | -$66.3M | -$101.7M | -$129.4M | -$96.2M | -$59.8M | |
| Net Interest Expenses | $5.7M | $4.6M | $50K | -- | -- | |
| EBT. Incl. Unusual Items | -$72.8M | -$106.9M | -$130.1M | -$77.4M | -$41.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$3.9M | $535K | -$839K | -$12K | $1.8M | |
| Net Income to Company | -$68.9M | -$107.5M | -$129.2M | -$77.4M | -$43.5M | |
| Minority Interest in Earnings | -- | -- | $802K | $2.2M | $801K | |
| Net Income to Common Excl Extra Items | -$68.9M | -$107.5M | -$128.4M | -$75.2M | -$42.7M | |
| Basic EPS (Cont. Ops) | -$0.87 | -$1.27 | -$1.45 | -$0.88 | -$0.59 | |
| Diluted EPS (Cont. Ops) | -$0.87 | -$1.27 | -$1.45 | -$0.88 | -$0.59 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$58.3M | -$95M | -$109M | -$52.8M | -$14.5M | |
| EBIT | -$63.5M | -$103.3M | -$126.5M | -$73M | -$35.1M | |
| Revenue (Reported) | $213.6M | $281.4M | $370.8M | $430.7M | $467.5M | |
| Operating Income (Reported) | -$66.3M | -$101.7M | -$129.4M | -$96.2M | -$59.8M | |
| Operating Income (Adjusted) | -$63.5M | -$103.3M | -$126.5M | -$73M | -$35.1M | |
| Period Ending | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | $281.4M | $370.8M | $430.7M | $467.5M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $48.4M | $70.4M | $77.8M | $79.7M | -- | |
| Gross Profit | $233M | $300.4M | $352.9M | $387.8M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $95.7M | $134.9M | $139.8M | $141.5M | -- | |
| Selling, General & Admin | $239.1M | $294.9M | $309.3M | $306.1M | -- | |
| Other Inc / (Exp) | -$573K | -$637K | $3.3M | -$215K | -- | |
| Operating Expenses | $334.7M | $429.7M | $449.1M | $447.6M | -- | |
| Operating Income | -$101.7M | -$129.4M | -$96.2M | -$59.8M | -- | |
| Net Interest Expenses | $4.6M | $1.3M | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$106.9M | -$130.1M | -$77.4M | -$41.8M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $535K | -$839K | -$12K | $1.8M | -- | |
| Net Income to Company | -$107.5M | -$129.2M | -$77.4M | -$43.5M | -- | |
| Minority Interest in Earnings | -- | $802K | $2.2M | $801K | -- | |
| Net Income to Common Excl Extra Items | -$107.5M | -$128.4M | -$75.2M | -$42.7M | -- | |
| Basic EPS (Cont. Ops) | -$1.27 | -$1.45 | -$0.88 | -$0.59 | -- | |
| Diluted EPS (Cont. Ops) | -$1.27 | -$1.45 | -$0.88 | -$0.59 | -- | |
| Weighted Average Basic Share | $338M | $354.8M | $369.8M | $368M | -- | |
| Weighted Average Diluted Share | $338M | $354.8M | $369.8M | $368M | -- | |
| EBITDA | -$95M | -$109M | -$52.8M | -$14.5M | -- | |
| EBIT | -$103.3M | -$126.5M | -$73M | -$35.1M | -- | |
| Revenue (Reported) | $281.4M | $370.8M | $430.7M | $467.5M | -- | |
| Operating Income (Reported) | -$101.7M | -$129.4M | -$96.2M | -$59.8M | -- | |
| Operating Income (Adjusted) | -$103.3M | -$126.5M | -$73M | -$35.1M | -- | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $339.2M | $349.8M | $274M | $363M | $346.5M | |
| Short Term Investments | $221.1M | $193.6M | $202.9M | $208.2M | $224.4M | |
| Accounts Receivable, Net | $55.1M | $75.3M | $91.3M | $100.4M | $107.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $10.6M | $9.8M | $13.4M | $12.1M | $13.8M | |
| Total Current Assets | $638.3M | $645.1M | $600.3M | $703.2M | $711.7M | |
| Property Plant And Equipment | $37.3M | $38.5M | $32.4M | $21.4M | $28.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $72.1M | $72.1M | $118.9M | $137.4M | $137.4M | |
| Other Intangibles | $26.6M | $23.1M | $37.2M | $32.6M | $20.9M | |
| Other Long-Term Assets | $1.8M | $1.5M | $1.4M | $5.6M | $3.9M | |
| Total Assets | $795.4M | $806.4M | $817.9M | $925.3M | $927.3M | |
| Accounts Payable | $5.7M | $9.5M | $7.4M | $6.2M | $7.3M | |
| Accrued Expenses | $8.3M | $12.6M | $10.1M | $14.5M | $17.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $57.4M | |
| Current Portion Of Capital Lease Obligations | $5.3M | $5.6M | $5.9M | $6.2M | $3.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $172.7M | $227M | $271.1M | $281.7M | $369.2M | |
| Long-Term Debt | $217.5M | $281.1M | $282.9M | $448M | $393.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $428.7M | $539.5M | $575.8M | $746.4M | $779.2M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $343K | -$669K | -$1.6M | -$733K | -$485K | |
| Common Equity | $366.7M | $267M | $241M | $171.6M | $129.8M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $1.1M | $7.3M | $18.2M | |
| Total Equity | $366.7M | $267M | $242.1M | $178.9M | $148M | |
| Total Liabilities and Equity | $795.4M | $806.4M | $817.9M | $925.3M | $927.3M | |
| Cash and Short Terms | $560.3M | $543.4M | $477M | $571.2M | $570.8M | |
| Total Debt | $217.5M | $281.1M | $282.9M | $448M | $450.7M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $339.2M | $349.8M | $274M | $363M | $346.5M | |
| Short Term Investments | $221.1M | $193.6M | $202.9M | $208.2M | $224.4M | |
| Accounts Receivable, Net | $55.1M | $75.3M | $91.3M | $100.4M | $107.4M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $10.6M | $9.8M | $13.4M | $12.1M | $13.8M | |
| Total Current Assets | $638.3M | $645.1M | $600.3M | $703.2M | $711.7M | |
| Property Plant And Equipment | $37.3M | $38.5M | $32.4M | $21.4M | $28.1M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $72.1M | $72.1M | $118.9M | $137.4M | $137.4M | |
| Other Intangibles | $26.6M | $23.1M | $37.2M | $32.6M | $20.9M | |
| Other Long-Term Assets | $1.8M | $1.5M | $1.4M | $5.6M | $3.9M | |
| Total Assets | $795.4M | $806.4M | $817.9M | $925.3M | $927.3M | |
| Accounts Payable | $5.7M | $9.5M | $7.4M | $6.2M | $7.3M | |
| Accrued Expenses | $8.3M | $12.6M | $10.1M | $14.5M | $17.1M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $57.4M | |
| Current Portion Of Capital Lease Obligations | $5.3M | $5.6M | $5.9M | $6.2M | $3.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $172.7M | $227M | $271.1M | $281.7M | $369.2M | |
| Long-Term Debt | $217.5M | $281.1M | $282.9M | $448M | $393.3M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $428.7M | $539.5M | $575.8M | $746.4M | $779.2M | |
| Common Stock | -- | -- | -- | -- | -- | |
| Other Common Equity Adj | $343K | -$669K | -$1.6M | -$733K | -$485K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $1.1M | $7.3M | $18.2M | |
| Total Equity | $366.7M | $267M | $242.1M | $178.9M | $148M | |
| Total Liabilities and Equity | $795.4M | $806.4M | $817.9M | $925.3M | $927.3M | |
| Cash and Short Terms | $560.3M | $543.4M | $477M | $571.2M | $570.8M | |
| Total Debt | $217.5M | $281.1M | $282.9M | $448M | $450.7M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$68.9M | -$107.5M | -$129.2M | -$77.4M | -$43.5M | |
| Depreciation & Amoritzation | $5.3M | $8.4M | $17.4M | $20.2M | $20.6M | |
| Stock-Based Compensation | $43.2M | $70M | $109.9M | $127.2M | $126.2M | |
| Change in Accounts Receivable | -$17.6M | -$21.6M | -$16.6M | -$10.7M | -$8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.1M | -$6M | $17M | $72M | $117.9M | |
| Capital Expenditures | $4.8M | $6.8M | $8.5M | $7.5M | $9.5M | |
| Cash Acquisitions | -$49.7M | -$160K | -$66.3M | -$24.1M | -- | |
| Cash From Investing | -$49.3M | $17.4M | -$86.2M | -$30.5M | -$20M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $278.2M | -- | -- | $390.8M | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$223.7M | -$403K | |
| Repurchase of Common Stock | -- | -- | -- | -$50M | -$100.1M | |
| Other Financing Activities | -$43.9M | -$23.6M | -$26.8M | -$85.7M | -$29M | |
| Cash From Financing | $254.4M | -$736K | -$6.4M | $51.6M | -$116.1M | |
| Beginning Cash (CF) | $124M | $339.2M | $349.8M | $274M | $366.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $215.1M | $10.6M | -$75.6M | $93M | -$18.2M | |
| Ending Cash (CF) | $339.2M | $349.8M | $274M | $366.7M | $348.3M | |
| Levered Free Cash Flow | $5.2M | -$12.8M | $8.5M | $64.4M | $108.4M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$22.1M | -$28.9M | -$25M | -$28.8M | -$8.9M | |
| Depreciation & Amoritzation | $1.9M | $2.2M | $4.7M | $5.1M | $5.1M | |
| Stock-Based Compensation | $11.5M | $22.2M | $23.4M | $32.2M | $29.1M | |
| Change in Accounts Receivable | -$13.8M | -$22M | -$19.6M | -$29.6M | -$32.8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.4M | $1.3M | $17.6M | $22.2M | $31.4M | |
| Capital Expenditures | $1.1M | $2.7M | $2M | $2.5M | $2.8M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.4M | -$11.8M | -$5.9M | -$37.4M | -$10.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$467K | -- | -- | -$712K | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -$204K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$2.6M | |
| Other Financing Activities | -$3.9M | -$5M | -$6.5M | -$6.6M | -$6.3M | |
| Cash From Financing | $2.5M | $477K | -$329K | -$2.1M | -$2.8M | |
| Beginning Cash (CF) | $336.7M | $359.7M | $262.3M | $383.9M | $330M | |
| Foreign Exchange Rate Adjustment | -- | -- | $336K | $50K | -$15K | |
| Additions / Reductions | $2.5M | -$10M | $11.4M | -$17.3M | $18.3M | |
| Ending Cash (CF) | $339.2M | $349.8M | $274M | $366.7M | $348.3M | |
| Levered Free Cash Flow | $2.3M | -$1.4M | $15.6M | $19.6M | $28.6M | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$68.9M | -$107.5M | -$129.2M | -$77.4M | -$43.5M | |
| Depreciation & Amoritzation | $5.3M | $8.4M | $17.4M | $20.2M | $20.6M | |
| Stock-Based Compensation | $43.2M | $70M | $109.9M | $127.2M | $126.2M | |
| Change in Accounts Receivable | -$17.6M | -$21.6M | -$16.6M | -$10.7M | -$8M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $10.1M | -$6M | $17M | $72M | $117.9M | |
| Capital Expenditures | $4.8M | $6.8M | $8.5M | $7.5M | $9.5M | |
| Cash Acquisitions | -$49.7M | -$160K | -$66.3M | -- | -- | |
| Cash From Investing | -$49.3M | $17.4M | -$86.2M | -$30.5M | -$20M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$43.9M | -$23.6M | -$26.8M | -$85.7M | -$29M | |
| Cash From Financing | $254.4M | -$736K | -$6.4M | $51.6M | -$116.1M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $215.1M | $10.6M | -$75.6M | $93M | -$18.2M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $5.2M | -$12.8M | $8.5M | $64.4M | $108.4M | |
| Period Ending | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2026-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$107.5M | -$129.2M | -$77.4M | -$43.5M | -- | |
| Depreciation & Amoritzation | $8.4M | $17.4M | $20.2M | $20.6M | -- | |
| Stock-Based Compensation | $70M | $109.9M | $127.2M | $126.2M | -- | |
| Change in Accounts Receivable | -$21.6M | -$16.6M | -$10.7M | -$8M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$6M | $17M | $72M | $117.9M | -- | |
| Capital Expenditures | $6.8M | $8.5M | $7.5M | $9.5M | -- | |
| Cash Acquisitions | -$160K | -$66.3M | -- | -- | -- | |
| Cash From Investing | $17.4M | -$86.2M | -$30.5M | -$20M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $390.8M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$223.7M | -$403K | -- | |
| Repurchase of Common Stock | -- | -- | -$50M | -$100.1M | -- | |
| Other Financing Activities | -$23.6M | -$26.8M | -$85.7M | -$29M | -- | |
| Cash From Financing | -$736K | -$6.4M | $51.6M | -$116.1M | -- | |
| Beginning Cash (CF) | $1.4B | $1.2B | $1.3B | $1.5B | -- | |
| Foreign Exchange Rate Adjustment | -- | -$168K | -$401K | -$124K | -- | |
| Additions / Reductions | $10.6M | -$75.6M | $93M | -$18.2M | -- | |
| Ending Cash (CF) | $1.4B | $1.1B | $1.4B | $1.5B | -- | |
| Levered Free Cash Flow | -$12.8M | $8.5M | $64.4M | $108.4M | -- | |
Get PD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PD
Sector
P/E ratio
--
20.40x
PEG ratio
--
0.01x
P/B ratio
10.14x
1.97x
Price / LTM sales
2.84x
1.43x
Growth Metrics
PD
Sector
Revenue growth
9.3%
4.79%
Earnings growth
--
11.5%
Revenue (5-year growth)
22.96%
6.66%
Earnings forecast
$0.16
$0.11
Profitability
PD
Sector
Profitability FY 2024
$387.8M
$90.3M
Return on invested capital
-6.96%
0.89%
Return on assets
-4.69%
0.13%
Return on equity
-25.94%
1.81%
Earnings Date
Last Earnings Date
Mar
13
Next Earnings Date
May
30
Estimated Next Earnings Date
Jun
12
Balance Sheet
PD
Sector
Total cash
$570.8M
$56M
Short term investments
$224.4M
$18.4M
Total assets
$927.3M
$248.3M
Long term debt
$450.7M
$7.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
61
AGX alert for Apr 23
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
